Detalles de la búsqueda
1.
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease.
J Pediatr
; 201: 166-175.e3, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054164
2.
Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
Gastroenterology
; 146(1): 110-118.e3, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24067881
3.
Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3.
Am J Gastroenterol
; 109(11): 1771-80, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25155227
4.
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.
Gastroenterology
; 142(5): 1102-1111.e2, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22326435
5.
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Gastroenterology
; 142(2): 257-65.e1-3, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22062358
6.
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.
Gastroenterology
; 143(2): 365-74.e2, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22562021
7.
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Gut
; 60(6): 780-7, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21209123
8.
Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial.
J Crohns Colitis
; 16(10): 1551-1561, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35526272
9.
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.
Lancet Gastroenterol Hepatol
; 6(8): 616-627, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34153231
10.
In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Cancer Epidemiol Biomarkers Prev
; 18(2): 433-43, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19190172
11.
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
J Crohns Colitis
; 13(9): 1227-1233, 2019 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726897
12.
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis.
Aliment Pharmacol Ther
; 49(2): 155-164, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506693
13.
Simultaneous fitting of real-time PCR data with efficiency of amplification modeled as Gaussian function of target fluorescence.
BMC Bioinformatics
; 9: 95, 2008 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18267040
14.
Pharmacogenetics of oral anticoagulants: a basis for dose individualization.
Clin Pharmacokinet
; 47(9): 565-94, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18698879
15.
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy.
Inflamm Intest Dis
; 2(4): 228-235, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221150
16.
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2.
J Crohns Colitis
; 12(10): 1249-1254, 2018 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29939254
17.
Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor.
FEBS J
; 274(3): 783-90, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17288558
18.
Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations.
Biochem Pharmacol
; 74(2): 309-16, 2007 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17532304
19.
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.
J Gastroenterol
; 52(9): 1031-1040, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28321512
20.
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.
J Crohns Colitis
; 11(11): 1317-1325, 2017 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28981846